Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation

Cell Death and Differentiation

Volumn 4, Issue 6, 1997, Pages 497-505

  Grande, Alexis ^a   Manfredini, Rossella ^a   Pizzanelli, Michela ^a   Tagliafico, Enrico ^a   Balestri, Raffaella ^a   Trevisan, Francesca ^a   Barbieri, Daniela ^a   Franceschi, Claudio ^a   Battini, Renata ^a   Ferrari, Stefano ^a   Ferrari, Sergio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

1,25 dihydroxyvitamin D3; Acute Myeloid Leukemia; DNA binding proteins; Monocytic differentiation; Transcriptional factors; Vitamin D receptor

Indexed keywords

EID: 0001405438     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400270     Document Type: Article

References (38)

1. Alam J and Cook JL (1990) Reporter genes: application to the study of mammalian gene transcription. Anal. Biochem. 188: 245-254
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33: 451-458
3. Breen EC, van Wijnen AJ, Lian JB, Stein GS, Stein JL (1994) In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells. Proc. Natl. Acad. Sci. USA 91: 12902-12906
4. Brown TA and DeLuca HF (1990) Phosphorylation of the 1,25-dihydroxyvitamin D3 receptor. A primary event in 1,25-dihydroxyvitamin D3 action. J. Biol. Chem. 265: 10025-10029
5. Burnette WN (1981) 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112: 195-203
6. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P, Degos L (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia: clinical results. Blood 76: 1704-1709
7. Collins SJ, Gallo RC, Gallagher RE (1977) Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270: 347-349
8. De Luca LM (1991) Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. Faseb. J. 5: 2924-2933
9. Delva L, Cornic M. Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, et al (1993) Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells [see comments]. Blood 82: 2175-2181
10. Dermime S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG, et al (1993) Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein. Blood 82: 1573-1577
11. Dore BT, Momparler RL (1996) Mutation in the ligand-binding domain of the retinoic acid receptor alpha in HL-60 leukemic cells resistant to retinoic acid and with increased sensitivity to vitamin D-3 analogs. Leuk. Res. 20: 761-769
12. Drexler HG (1987) Classification of acute myeloid leukemias - a comparison of FAB and immunophenotyping. Leukemia 1: 697-705
13. Duits AJ, Dimjati W, van de Winkel JG, Capel PJ (1992) Synergism of interleukin 6 and 1 alpha,25-dihydroxyvitamin D3 in induction of myeloid differentiation of human leukemic cell lines. J. Leukoc. Biol. 51:237-243
14. el Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
15. Feldman J, Federico MH, Sonohara S, Katayama ML, Koike MA, Roela RA, da Silva MR, Brentani MM (1993) Vitamin D3 binding activity during leukemic cell differentiation. Leuk. Res. 17: 97-101
16. Ferrari S, Battini R, Molinari S (1994) Specific binding to vitamin D response elements of chicken intestinal DNA-binding activity is not related to the vitamin D receptor. Mol. Endocrinol. 8: 173-181
17. Ferrari S, Battini R, Pike WJ (1990) Functional analysis of the promoter region of the gene encoding chicken calbindin D28K. Adv. Exp. Med. Biol. 269: 21-25
18. Ferrari S, Donelli A, Manfredini R, Sarti M, Roncaglia R, Tagliafico E, Rossi E, Torelli G, Torelli U (1990) Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells. Cell Growth Differ. 1: 543-548
19. Ferrari S, Grande A, Manfredini R, Tagliafico E, Zucchini P, Torelli G, Torelli U (1993) Expression of interleukins 1, 3, 6, stem cell factor and their receptors in acute leukemia blast cells and in normal peripheral lymphocytes and monocytes. Eur. J. Haematol. 50: 141-148
20. Imai Y, Pike JW, Koeffler HP (1995) Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element. Leuk. Res. 19: 147-158.
21. Jin CH, Kerner SA, Hong MH, Pike JW (1996) Transcriptional activation and dimerization functions in the human vitamin D receptor. Molecular Endocrinology 10:945-957
22. Kadonaga JT and Tjian R (1986) Affinity purification of sequence-specific DNA binding proteins. Proc. Natl. Acad. Sci. USA 83: 5889-5893
23. Kasukabe T, Honma Y, Hozumi M, Suda T, Nishii Y (1987) Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies. Cancer Res. 47: 567-572
24. Kelsey SM, Makin HL, Newland AC (1992) Functional significance of induction of differentiation in human myeloid leukaemic blasts by 1,25-dihydroxyvitamin D3 and GM-CSF. Leuk. Res. 16: 427-434
25. Kiefer MC, Saphire AC, Bauer DM, Barr PJ (1990) The cDNA and derived amino acid sequences of human and bovine bone Gla protein. Nucleic. Acids. Res. 18: 1909
26. Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW (1980) An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56: 265-273
27. Koeffler HP and Golde DW (1978) Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200: 1153-1154
28. Lange B, Valtieri M, Santoli D, Caracciolo D, Mavilio F, Gemperlein I, Griffin C, Emanuel B, Finan J, Nowell P, et al (1987) Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 70: 192-199
29. MacDonald RJ, Swift GH, Przybyla AE, Chirgwin JM (1987) Isolation of RNA using guanidinium salts. Methods Enzymol. 152: 219-227
30. Manfredini R, Grande A, Tagliafico E, Barbieri D, Zucchini P, Citro G, Zupi G, Franceschi C, Torelli U, Ferrari S (1993) Inhibition of c-fes expression by an antisense oligomer causes apoptosis of HL60 cells induced to granulocytic differentiation. J. Exp. Med. 178: 381-389
31. Miller CW and Koeffler HP (1990) In vivo and in vitro differentiation of myeloid leukemic cells. In: Mauer AM (ed) The biology of human leukemia. (Baltimore and London, The John Hopkins University Press) pp. 152-176
32. Okabe-Kado J, Honma Y, Hayashi M, Hozumi M (1991) Effects of transforming growth factor-beta and activin A on vitamin D3- induced monocytic differentiation of myeloid leukemia cells. Anticancer Res. 11: 181-186
33. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW (1990) The vitamin D-responsive element in the human osteocalcin gene. Association with a nuclear protooncogene enhancer. J. Biol. Chem. 265: 21881-21888
34. Pols HA, Birkenhager JC, Foekens JA, van Leeuwen JP (1990) Vitamin D: a modulator of cell proliferation and differentiation. J. Steroid Biochem. Mol. Biol. 37: 873-876
35. Suggs SV, Wallace RB, Hirose T, Kawashima EH, Itakura K (1992) Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. 1981 [classical article]. Biotechnology 24: 140-144
36. Sundstrom C and Nilsson K (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer 17: 565-577
37. Thomas ML (1989) The leukocyte common antigen family. Annu. Rev. Immunol. 7: 339-369
38. Torelli U, Ferrari S, Manfredini R (1994) Proliferation, differentiation and programmed cell death: an outline of their genetic control and disorders in normal and leukemic myelopoiesis. In: Cacciola E, Deisserroth AB, Giustolisi R eds Hemopoietic growth factors, oncogenes and cytokines in clinical hematology. (Basel, Basel Karger) pp. 49-63